Unknown

Dataset Information

0

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma.


ABSTRACT: With underrepresentation of elderly patients with lung adenocarcinoma (LADC) in anti-PD-1/PD-L1 clinical trials, better understanding of the interplay of PD-L1 and tumor-associated immune cells (TAICs) could assist clinicians in stratifying these patients for immunotherapy. One hundred and one patients with LADCs, stratified by age, were included for analysis of PD-L1 expression and density of TAICs expressing CD4, CD8, and CD33, by using multiplex chromogenic immunohistochemistry (IHC) assays and automated digital quantification. The CD4?/CD8? ratio was significantly higher in elderly patients. In patients <75 years, the density of CD4?, CD8?, and PD-L1 in TAICs showed a positive significant correlation with PD-L1 expression in tumor cells (TCs), while a lower correlation was observed in the elderly population. In the latter, a high CD4?/CD8? ratio, and combined PD-L1 expression ?1% TCs with a low CD8? density, low CD33? density, and a high CD4? density correlated to worse overall survival. We identified differences according to age in the CD4?/CD8? ratio and in correlation between PD-L1 expression and the density of TAICs in LADC patients. Distinct groups of tumor microenvironments had an impact on the OS of elderly patients with LADC.

SUBMITTER: Ilie M 

PROVIDER: S-EPMC6162494 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


With underrepresentation of elderly patients with lung adenocarcinoma (LADC) in anti-PD-1/PD-L1 clinical trials, better understanding of the interplay of PD-L1 and tumor-associated immune cells (TAICs) could assist clinicians in stratifying these patients for immunotherapy. One hundred and one patients with LADCs, stratified by age, were included for analysis of PD-L1 expression and density of TAICs expressing CD4, CD8, and CD33, by using multiplex chromogenic immunohistochemistry (IHC) assays a  ...[more]

Similar Datasets

| S-EPMC6310091 | biostudies-literature
| S-EPMC10651111 | biostudies-literature
| S-EPMC9272556 | biostudies-literature
| S-EPMC7811787 | biostudies-literature
| S-EPMC8440021 | biostudies-literature
| S-EPMC8277384 | biostudies-literature
| S-EPMC8312618 | biostudies-literature
| S-EPMC8851380 | biostudies-literature
| S-EPMC10540310 | biostudies-literature
| S-EPMC10042817 | biostudies-literature